Chronic Radiation Enteritis

被引:151
作者
Theis, V. S. [1 ]
Sripadam, R. [2 ]
Ramani, V. [2 ]
Lal, S. [3 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Digest Dis Unit, Liverpool L9 7AL, Merseyside, England
[2] Clatterbridge Ctr Oncol, Bebington, Merseyside, England
[3] Salford Royal NHS Fdn Trust, Intestinal Failure Unit, Salford, Lancs, England
关键词
Bacterial overgrowth; chronic radiation enteritis; malabsorption; nutrition; radiotherapy; INTENSITY-MODULATED RADIOTHERAPY; SMALL-BOWEL TOXICITY; ADVANCED RECTAL-CANCER; IMAGE-GUIDED RADIOTHERAPY; DOSE-VOLUME RELATIONSHIPS; TOTAL MESORECTAL EXCISION; SMOOTH-MUSCLE-CELLS; BELLY BOARD DEVICE; TERM-FOLLOW-UP; PREOPERATIVE RADIOTHERAPY;
D O I
10.1016/j.clon.2009.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Chronic radiation enteritis is an increasing problem, as more patients receive radiotherapy as part of their cancer therapy and as the long-term survival of these patients improves. This review addresses the causes, investigation, treatment and prevention of this disease. A review of published studies was carried out using a variety of search terms, including radiation enteritis, investigation, treatment and prevention. Chronic radiation enteritis has been reported in up to 20% of patients receiving pelvic radiotherapy, although this may underestimate its true prevalence, as not all patients with gastrointestinal symptoms after radiotherapy will seek medical attention. Predisposing factors to chronic radiation enteritis include a low body mass index, previous abdominal surgery and the presence of co-morbid conditions; the radiation dose, fractionation and technique, as well as the concomitant use of chemotherapy, may also play a role. Clinical features of chronic radiation enteritis are multiple as the disease can affect any part of the gastrointestinal tract. Moreover, symptom aetiology within any one patient may be multifactorial and therefore it is important to adopt a structured approach when planning investigations. The evidence base for current therapies is limited, but nutrition, anti-diarrhoeals, anti-inflammatories, antibiotics, probiotics, pentoxifylline, tocopherol, cholestyramine, hyperbaric oxygen, endoscopic and surgical therapies have all received attention. Given the significant morbidity and mortality associated with chronic radiation enteritis, current available preventative strategies are reviewed, including tissue-sparing radiotherapy techniques. In conclusion, the evidence base for therapeutic and preventative strategies in treating chronic radiation enteritis is limited, but adopting a structured approach to investigating gastrointestinal symptoms after radiotherapy should allow better targeting of current therapies. Closer collaboration between oncologists and gastroenterologists will facilitate a more structured approach, not only in managing individual patients, but also in establishing clinical and research networks for this expanding disease, in order to improve the evidence base for its management. (C) 2009 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:70 / 83
页数:14
相关论文
共 180 条
[1]
Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer? [J].
Adli, M ;
Mayr, NA ;
Kaiser, HS ;
Skwarchuk, MW ;
Meeks, SL ;
Mardirossian, G ;
Paulino, AC ;
Montebello, JF ;
Gaston, RC ;
Sorosky, JI ;
Buatti, JM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (01) :230-238
[2]
Inter-fraction bladder filling variations and time trends for cervical cancer patients assessed with a portable 3-dimensional ultrasound bladder scanner [J].
Ahmad, Rozilawati ;
Hoogeman, Mischa S. ;
Quint, Sandra ;
Mens, Jan Willem ;
de Pree, Ilse ;
Heijmen, Ben J. M. .
RADIOTHERAPY AND ONCOLOGY, 2008, 89 (02) :172-179
[3]
Impact of the "belly board" device on treatment reproducibility in preoperative radiotherapy for rectal cancer [J].
Allal, AS ;
Bischof, S ;
Nouet, P .
STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (05) :259-262
[4]
Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future [J].
Andreyev, H. J. N. .
CLINICAL ONCOLOGY, 2007, 19 (10) :790-799
[5]
Gastrointestinal symptoms after pelvic radiotherapy: Role for the gastroenterologist? [J].
Andreyev, HJN ;
Vlavianos, P ;
Blake, P ;
Dearnaley, D ;
Norman, AR ;
Tait, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (05) :1464-1471
[6]
Gastrointestinal complications of pelvic radiotherapy: are they of any importance? [J].
Andreyev, J .
GUT, 2005, 54 (08) :1051-1054
[7]
Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients [J].
Andreyev, Jervoise .
LANCET ONCOLOGY, 2007, 8 (11) :1007-1017
[8]
[Anonymous], GUIDELINES MANAGEMEN
[9]
Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer [J].
Antonadou, D ;
Pepelassi, M ;
Synodinou, M ;
Puglisi, M ;
Throuvalas, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03) :739-747
[10]
Ares DM, 2004, REV ESP ENFERM DIG, V96, P132, DOI 10.4321/s1130-01082004000200006